Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

Abstract Cancer immunotherapies, represented by immune checkpoint inhibitors (ICIs), have reshaped the treatment paradigm for both advanced non-small cell lung cancer and small cell lung cancer. Programmed death receptor-1/programmed death receptor ligand-1 (PD-1/PD-L1) and cytotoxic T lymphocyte-as...

Полное описание

Библиографические подробности

Главные авторы:	Weishi Cheng, Kai Kang, Ailin Zhao, Yijun Wu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2024-07-01
Серии:	Journal of Hematology & Oncology
Предметы:	Lung cancer Immune checkpoint inhibitor Bispecific antibody Combination therapy Biomarker
Online-ссылка:	https://doi.org/10.1186/s13045-024-01581-2
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!